O'Domhnaill Enterprises’s Amgen AMGN Stock Holding History

O'Domhnaill Enterprises’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2K	Hold	64	–	–	0.02%	56
2026 Q1	$22.5K	Hold	64	–	–	0.02%	51
2025 Q4	$20.9K	Buy	+64	New	+$20.3K	0.02%	48

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

O'Domhnaill Enterprises's AMGN Position: Q2 2026 in Review

O'Domhnaill Enterprises held its Amgen (AMGN) position steady in Q2 2026 at 64 shares worth $23.2K. The position accounts for 0.02% of the portfolio, ranked #56.

O'Domhnaill Enterprises first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

O'Domhnaill Enterprises held 64 shares of Amgen worth $23.2K as of Q2 2026.
O'Domhnaill Enterprises left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.02% of O'Domhnaill Enterprises's portfolio in Q2 2026, its #56 holding.
O'Domhnaill Enterprises first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on O'Domhnaill Enterprises's 13F filing for Q2 2026, filed 30 Jul 2026.